TFX: Teleflex Incorporated Stock

by  •  • Comments Off on TFX: Teleflex Incorporated Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 9,736.30
Enterprise Value ($M) 11,328.52
Book Value ($M) 4,440.99
Book Value / Share 94.29
Price / Book 2.19
NCAV ($M) -1,684.15
NCAV / Share -35.76
Price / NCAV -5.78

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.09

Liquidity (mrq)
Quick Ratio 1.29
Current Ratio 2.32

Balance Sheet (mrq) ($M)
Current Assets 1,407.41
Assets 7,532.55
Liabilities 3,091.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,974.49
Operating Income 517.47
Net Income 356.33
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 510.64
Cash from Investing -621.23
Cash from Financing 38.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A T. Rowe Price Investment Management, Inc. 15.00 -18.46
02-13 13G/A Janus Henderson Group Plc 10.30 0.00
02-13 13G/A Vanguard Group Inc 11.61 0.62
02-09 13G/A Morgan Stanley 5.50 2.51
02-08 13G/A Wellington Management Group Llp 5.31 -19.28
01-24 13G/A BlackRock Inc. 9.10 8.02

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K _________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 1, 2023 OR ☐ TRANSITION REPO
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 2, 2023 OR ☐ TRANSITION REPORT
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 02, 2023 OR ☐ TRANSITION REPOR

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 25,512 340,260 7.50
2024-04-25 26,608 345,088 7.71
2024-04-24 20,382 201,415 10.12
2024-04-23 22,507 284,357 7.92
2024-04-22 30,524 329,746 9.26

(click for more detail)

Similar Companies
STE – STERIS plc STVN – Stevanato Group S.p.A.
SYK – Stryker Corporation WST – West Pharmaceutical Services, Inc.


Financial data and stock pages provided by
Fintel.io